Class 2 MHRA Medicines recall: Losartan Potassium 50mg and 100mg Film-coated Tablets (Accord Healthcare Limited)

Class 2 MHRA Medicines recall: Losartan Potassium 50mg and 100mg Film-coated Tablets (Accord Healthcare Limited)

March 21, 2019

Drug alert number: EL (19) A/07

Date issued: 21st March 2019

The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 pharmacy level medicines recall, to be actioned within 48 hours, for certain batches of  Losartan 50mg and 100mg containing products. Accord Healthcare Limited is recalling the batches identified below from pharmacies as a precautionary measure due to possible contamination with N-nitroso-N-methylamino butyric acid (NMBA)

Losartan Potassium 50mg Film-coated tablets PL 20075/0022

Batch Number Expiry Date Pack Size First Distributed
PT04882 Nov 2019 1 x 28   28/03/2018

Losartan Potassium 100mg Film-coated tablets PL 20075/0023

Batch Number Expiry Date Pack Size First Distributed
PT02738 June 2019 1 x 28   27/02/2017
GX0135 Aug 2020 1 x 28   07/02/2019

Community pharmacy teams should stop supplying the above products/batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.

To view the alert please visit the GOV.UK website.

Company contacts for further information

For stock control enquiries please contact Accord Customer Services on 0800 373573.

For medical information enquiries please contact Accord Medical Information Department on 01271 385257



Posted in: ,


More Latest News >

Shortage Notice: Salbutamol 2mg/5ml syrup

GlaxoSmithKline (GSK) and Pinewood, the manufacturers of Salbutamol 2mg/5ml syrup, are currently experiencing temporary disruptions. GSK, the main supplier of Salbutamol...